# Ultrasensitive Detection of FKBP12 Using a Synthetic Receptor-Functionalized QCM Nanoplatform

> Source page: https://openqcm.com/scientific-papers/ultrasensitive-detection-of-fkbp12-using-a-synthetic-receptor-functionalized-qcm-nanoplatform
> Markdown version for AI agents and readers of plain text. Site guide: https://openqcm.com/llms.txt · Everything in one file: https://openqcm.com/llms-full.txt

- Authors: Martina Tozzetti, Maria Raffaella Martina, Giacomo Lucchesi, Kristian Vasa, Ahtsham Ishaq, Laura Marsili, Piero Procacci, Stefano Menichetti, Gabriella Caminati
- Journal: Advanced Sensor Research
- Year: 2025
- Pages: e00053
- DOI: 10.1002/adsr.202500053
- Instrument used: openQCM Wi2

## Abstract

Abstract FKBP12, a peptidyl-prolyl isomerase implicated in cancer, neurodegenerative diseases, and post-transplant anti-rejection mechanisms, represents a critical biomarker for early diagnosis and monitoring. Here, a novel diagnostic nanoplatform is presented for the detection of FKBP12 at nanomolar to picomolar concentrations in biological fluids. The platform integrates a gold-coated Quartz Crystal Microbalance (QCM) functionalized with a synthetic receptor (GPS-SH1) and spacers within a Self-Assembled Monolayer (SAM), enabling direct and label-free detection of FKBP12 in complex biological samples. A careful strategy for the in-silico design and custom synthesis of the receptor is adopted, ensuring optimal binding affinity and additional chemical functionalities for surface chemisorption. The designed nano-architecture demonstrates exceptional sensitivity, with a detection limit in the picomolar range, and high selectivity, as confirmed by minimal interference from abundant serum proteins such as Serum Albumin and Immune Gamma Globulin. Furthermore, the SAM-functionalized sensors exhibit remarkable stability, retaining functionality for up to six months under storage conditions. This work not only advances the field of nanoscale biosensing but also provides a robust, reusable tool for FKBP12 detection, with potential applications in point-of-care diagnostics and personalized medicine. The platform's ability to operate in biologically relevant environments underscores its promise for real-world healthcare applications, including early disease diagnostics.

---

openQCM by Novaetech S.r.l., Pompeii, Italy · Buy: https://store.openqcm.com/ · Contact: info@openqcm.com · https://openqcm.com/contacts/